Related Experiment Videos
Engineering a bioluminescent indicator for cyclic AMP-dependent protein kinase.
1Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff, U.K.
The Biochemical Journal
|November 1, 1991
Summary
Researchers engineered firefly luciferase to detect cyclic AMP-dependent protein kinase phosphorylation. A specific mutant (RRFS) showed altered properties and activity reduction upon phosphorylation, making it a promising tool for live-cell studies.
Area of Science:
- Biochemistry
- Molecular Biology
- Biotechnology
Background:
- Cyclic AMP-dependent protein kinase (PKA) is crucial in cellular signaling pathways.
- Monitoring PKA activity in real-time within live cells is challenging.
- Firefly luciferase is a versatile reporter protein for biological processes.
Purpose of the Study:
- To engineer firefly luciferase to incorporate PKA phosphorylation sites.
- To create a novel biosensor for detecting PKA-mediated phosphorylation.
- To characterize the properties of the engineered luciferase variants.
Main Methods:
- In vitro amplification of Photinus pyralis luciferase cDNA.
- Site-directed mutagenesis to introduce RRFS phosphorylation site.
- Addition of kemptide sequence to N- or C-terminus.
- In vitro transcription and translation of engineered genes.
- Characterization of recombinant proteins: specific activity, pI, pH-dependent spectral shift, and kinase/phosphatase assays.
Main Results:
- Engineered luciferase variants were successfully produced.
- The RRFS mutant exhibited significantly altered properties compared to wild-type luciferase.
- RRFS mutant showed reduced specific activity, a lower pH optimum, and a greener light emission at low pH.
- Phosphorylation of RRFS mutant by PKA catalytic subunit decreased its activity by up to 80%, reversible by phosphatase.
Conclusions:
- The RRFS mutant firefly luciferase is a sensitive reporter for PKA activity.
- This engineered protein enables the measurement of cyclic AMP-dependent phosphorylation in live cells for the first time.
- The developed biosensor holds potential for advancing research in cellular signaling and drug discovery.